Serum bromide concentrations following loading dose in epileptic dogs

Area of Science:

• Veterinary Neurology
• Clinical Pharmacology
• Canine Therapeutics

Background:

• Epilepsy is a common neurological disorder in dogs.
• Potassium bromide is an established anticonvulsant medication.
• Optimizing bromide dosing is crucial for effective seizure control.

Purpose of the Study:

• To evaluate serum bromide concentrations after an oral loading dose in dogs.
• To assess the efficacy of a specific potassium bromide loading protocol.

Main Methods:

• Retrospective review of clinical records for dogs treated with potassium bromide.
• Administration of a loading dose (600 mg/kg) followed by a maintenance dose (30 mg/kg/day).
• Serum bromide levels measured via ultra-violet gold chloride colorimetric assay.

Main Results:

• Thirty-eight dogs were analyzed.
• Median serum bromide concentration was 1.26 mg/mL.
• 84.2% of dogs achieved therapeutic serum bromide concentrations (1-3 mg/mL).

Conclusions:

• The oral loading dose protocol rapidly achieves therapeutic bromide levels in the majority of epileptic dogs.
• This protocol is effective for achieving therapeutic concentrations quickly.
• The findings support the use of this protocol for managing canine epilepsy.